EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PathDIP 5: improving coverage and making enrichment analysis more biologically meaningful

Chiara Pastrello iD, Max Kotlyar iD, Mark Abovsky, Richard Lu, Igor Jurisica iD

Nucleic Acids Research · 05.01.2024 · 52 (D1) · D663-D671

DOI: 10.1093/nar/gkad1027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 22.11.2023. Verfasst von Chiara Pastrello und 4 weiteren Autor:innen. Beteiligte Einrichtung: Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, Toronto, Ontario M5T 0S8, Canada. Hauptthemen laut MEDLINE: Databases, Factual, Gene Regulatory Networks. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences Research Council, Canada Foundation for Innovation, Ontario Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathway Data Integration Portal (PathDIP) is an integrated pathway database that was developed to increase functional gene annotation coverage and reduce bias in pathway enrichment analysis. PathDIP 5 provides multiple improvements to enable more interpretable analysis: users can perform enrichment analysis using all sources, separate sources or by combining specific pathway subsets; they can select the types of sources to use or the types of pathways for the analysis, reducing the number of resulting generic pathways or pathways not related to users’ research question; users can use API. All pathways have been mapped to seven representative types. The results of pathway enrichment can be summarized through knowledge-based pathway consolidation. All curated pathways were mapped to 53 pathway ontology-based categories. In addition to genes, pathDIP 5 now includes metabolites. We updated existing databases, included two new sources, PathBank and MetabolicAtlas, and removed outdated databases. We enable users to analyse their results using Drugst.One, where a drug-gene network is created using only the user's genes in a specific pathway. Interpreting the results of any analysis is now improved by multiple charts on all the results pages. PathDIP 5 is freely available at https://ophid.utoronto.ca/pathDIP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Databases, FactualGene Regulatory NetworksMolecular Sequence AnnotationSoftwareInternet

Autor:innen und Institutionen

  • Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, Toronto, Ontario M5T 0S8, Canada.
  • Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, Krembil Discovery Tower, Toronto, ON M5T 0S8, Canada.
  • Departments of Medical Biophysics and Computer Science, and Faculty of Dentistry, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.

ORCID-Profile: Chiara Pastrello, Max Kotlyar, Igor Jurisica

Förderung

  • Natural Sciences Research Council
  • Canada Foundation for Innovation
  • Ontario Research Fund
  • Ian Lawson van Toch Fund

Zitieren

APA

Pastrello, C., Kotlyar, M., Abovsky, M., Lu, R., & Jurisica, I. (2024). PathDIP 5: improving coverage and making enrichment analysis more biologically meaningful. Nucleic Acids Research, 52(D1), D663-D671. https://doi.org/10.1093/nar/gkad1027

Vancouver

Pastrello C, Kotlyar M, Abovsky M, Lu R, Jurisica I. PathDIP 5: improving coverage and making enrichment analysis more biologically meaningful. Nucleic Acids Research. 2024;52(D1):D663-D671. doi:10.1093/nar/gkad1027

BibTeX
@article{Pastrello2024,
  author = {Pastrello, Chiara and Kotlyar, Max and Abovsky, Mark and Lu, Richard and Jurisica, Igor},
  title = {PathDIP 5: improving coverage and making enrichment analysis more biologically meaningful},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {D1},
  pages = {D663--D671},
  doi = {10.1093/nar/gkad1027}
}
Kostenlos starten →